$11.3 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 85 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PLYA | PLAYA HOTELS & RESORTS NV | $319,230,000 | -12.7% | 30,606,930 | 0.0% | 2.84% | -25.3% | |
HERBALIFE LTDnote 2.000% 8/1 | $108,286,000 | -3.9% | 108,177,000 | 0.0% | 0.96% | -17.8% | ||
ANTM | ANTHEM INC | $39,875,000 | +0.9% | 210,000 | 0.0% | 0.35% | -13.7% | |
SLD | SUTHERLAND ASSET MGMT CORP M | $36,491,000 | +5.7% | 2,324,236 | 0.0% | 0.32% | -9.5% | |
SVRA | SAVARA INC | $20,804,000 | +59.0% | 2,225,000 | 0.0% | 0.18% | +36.0% | |
AKBA | AKEBIA THERAPEUTICS INC | $14,359,000 | +36.9% | 730,000 | 0.0% | 0.13% | +17.4% | |
WGL | WGL HLDGS INC | $10,104,000 | +0.9% | 120,000 | 0.0% | 0.09% | -13.5% | |
PCO | PENDRELL CORPcl a new | $5,608,000 | -5.5% | 821,061 | 0.0% | 0.05% | -19.4% | |
QCOM | QUALCOMM INC | $4,406,000 | -6.1% | 85,000 | 0.0% | 0.04% | -20.4% | |
BKD | BROOKDALE SR LIVING INC | $3,498,000 | -27.9% | 330,000 | 0.0% | 0.03% | -38.0% | |
GCVRZ | SANOFIright 12/31/2020 | $2,458,000 | -5.3% | 6,827,805 | 0.0% | 0.02% | -18.5% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
GRIFOLS S A | 33 | Q4 2021 | 0.9% |
ALPHABET INC | 32 | Q3 2023 | 4.2% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
VISA INC | 30 | Q3 2023 | 2.9% |
WABTEC CORP | 27 | Q3 2023 | 3.6% |
EXELIXIS INC | 27 | Q3 2023 | 2.8% |
ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
Solid Power, Inc. | February 11, 2022 | ? | ? |
Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR | 2024-02-14 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.